1. Home
  2. MRVI vs XPOF Comparison

MRVI vs XPOF Comparison

Compare MRVI & XPOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • XPOF
  • Stock Information
  • Founded
  • MRVI 2014
  • XPOF 2017
  • Country
  • MRVI United States
  • XPOF United States
  • Employees
  • MRVI N/A
  • XPOF N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • XPOF Services-Misc. Amusement & Recreation
  • Sector
  • MRVI Health Care
  • XPOF Consumer Discretionary
  • Exchange
  • MRVI Nasdaq
  • XPOF Nasdaq
  • Market Cap
  • MRVI 312.4M
  • XPOF 295.1M
  • IPO Year
  • MRVI 2020
  • XPOF 2021
  • Fundamental
  • Price
  • MRVI $2.22
  • XPOF $9.13
  • Analyst Decision
  • MRVI Hold
  • XPOF Buy
  • Analyst Count
  • MRVI 10
  • XPOF 9
  • Target Price
  • MRVI $6.84
  • XPOF $13.94
  • AVG Volume (30 Days)
  • MRVI 1.9M
  • XPOF 793.7K
  • Earning Date
  • MRVI 05-12-2025
  • XPOF 07-31-2025
  • Dividend Yield
  • MRVI N/A
  • XPOF N/A
  • EPS Growth
  • MRVI N/A
  • XPOF N/A
  • EPS
  • MRVI N/A
  • XPOF N/A
  • Revenue
  • MRVI $241,856,000.00
  • XPOF $317,536,000.00
  • Revenue This Year
  • MRVI N/A
  • XPOF $1.58
  • Revenue Next Year
  • MRVI $10.73
  • XPOF $6.40
  • P/E Ratio
  • MRVI N/A
  • XPOF N/A
  • Revenue Growth
  • MRVI N/A
  • XPOF N/A
  • 52 Week Low
  • MRVI $1.67
  • XPOF $6.64
  • 52 Week High
  • MRVI $10.03
  • XPOF $18.95
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 52.01
  • XPOF 54.06
  • Support Level
  • MRVI $2.20
  • XPOF $8.84
  • Resistance Level
  • MRVI $2.41
  • XPOF $9.38
  • Average True Range (ATR)
  • MRVI 0.15
  • XPOF 0.55
  • MACD
  • MRVI 0.01
  • XPOF 0.05
  • Stochastic Oscillator
  • MRVI 58.06
  • XPOF 66.09

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About XPOF Xponential Fitness Inc.

Xponential Fitness Inc is a curator of boutique fitness brands. Its diversified portfolio of brands includes Club Pilates, a Pilates brand in the United States; CycleBar, an indoor cycling brand in the United States; StretchLab, a concept offering one-on-one and group stretching services; Row House, a high-energy, low-impact indoor rowing workout; AKT, a dance-based cardio workout combining toning, interval and circuit training; YogaSix a franchised yoga brand; Pure Barre, a total body workout that uses the ballet barre to perform small isometric movements; Stride, a treadmill-based cardio and strength training concept; Rumble, a boxing-inspired full-body workout; and BFT, a functional training and strength-based program. Its key revenue source is franchise income.

Share on Social Networks: